Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorEnte Ospedaliero Ospedali Galliera

About this trial

This is a bicentric, prospective, non-pharmacological, randomized study designed to compare the efficacy and safety of awake neuraxial anesthesia with sedation versus general anesthesia in frail patients undergoing elective major laparoscopic or robotic abdominopelvic surgery.

A total of 100 frail patients aged over 60 years, with ASA physical status \>2 and evidence of frailty and/or cognitive vulnerability, will be randomized to receive either standard general anesthesia with mechanical ventilation or thoracic neuraxial anesthesia combined with non-GABAergic sedation while maintaining spontaneous breathing.

The primary objective is to evaluate the feasibility in terms of recruitment of a RCT conducted in a population of frail or cognitively impaired patients undergoing major laparoscopic abdominal surgery, randomized to a neuraxial or general anesthetic approach in which the effects on the onset of postoperative delirium and postoperative cognitive dysfunction (POCD) will be determined. Secondary outcomes include the occurrence of postoperative organ dysfunction (respiratory, cardiovascular, renal, and metabolic), length of hospital stay, time to recovery after surgery, and postoperative mortality.

Patients will undergo comprehensive perioperative clinical, laboratory, and ultrasound assessments, including lung and renal ultrasound evaluations. Neurological and functional status will be assessed during hospitalization, at 1 month, and via telephone follow-up at 1 year after surgery.

The aim of the study is to evaluate the feasibility and safety of performing two different anesthetic techniques on fragile patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 60 years

Willingness to participate in the study and written informed consent

ASA physical status > 2

Frailty score > 5 and/or AMT-10 < 6

Disqualifiers

coagulation disorders

severe spinal deformities

known allergy to local anesthetics

severe aortic stenosis

Trial design

Design model

Parallel

Treatments tested in this trial

  • Neuraxial anesthesia

    Procedure/Surgery

    patients undergo surgery with a neuraxial anesthesia based on spinal or epidural anesthesia using local anesthetics combined with sedation.

  • General Anesthesia

    Procedure/Surgery

    patients undergo surgery with a general anesthesia using classical GABAergic-drugs.

  • avoidance of GABAergic-drugs strategy

    Drug

    Sedation based on dexmedetomidine and low dosage of ketamine, avoiding GABAergic-drugs

  • use of GABAergic-drugs

    Drug

    General anesthesia using classical GABAergic-drugs such as propofol, remifentanil and rocuronium.

  • mechanical ventilation (MV)

    Procedure/Surgery

    Abdomino-pelvic Surgery managed in general anesthesia needs orotracheal intubation and mechanical ventilation

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: neuraxial anesthesia combined with sedationActive comparator 2 interventions
Group B: General anesthesiaActive comparator 3 interventions

Trial outcomes

Primary outcomes

1

Number of patients effectively managed with neuraxial approach

Evaluate feasibility in terms of number of patients recruited and number of patients randomized to neuraxial anesthetic approach effectively managed in neuraxial anesthetic approach throughout all the procedure.

Time frame
Periprocedural

Secondary outcomes

1

Postoperative cognitive disfunction

Postoperative cognitive dysfunction will be assessed using the Montreal Cognitive assessment (MoCA). A MoCA score \> 26 will be considered normal, where as a score \< 26 will indicated cognitive dysfunction. Lower scores correspond to grater severity of detected cognitive impairment.

Time frame
The moment of enrollement and at 30 days follow-up and one year.
2

Postoperative delirium.

Postoperative delirium will be assessed using 3D CAM, on a rating scale where a value of 0 indicates no delirium and a maximum value of 7 indicates the most severe degree.

Time frame
The moment of enrollement, post operative 0,1,2,3 and day of discharge.
3

Polmonary complications.

Pulmonary complications will be assessed through a lung ultrasound (lung pocus), the score of which includes a minimum value of 0 representing normality and a maximum value of 36 describing the presence of widespread consolidation in all 12 lung areas explored.

Time frame
The moment of enrollement, postoperative days 1,2,3.
4

Renal function

Postoperative renal function is assessed using the KDIGO score, where 1 represents mild renal insufficiency and 3 represents severe renal insufficiency.

Time frame
Day of enrollement, postoperative days 1,2,3.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: